Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,948 | 549 | 97.1% |
| Gift | $250.00 | 1 | 2.7% |
| Education | $17.52 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,771 | 107 | $0 (2024) |
| Amgen Inc. | $1,088 | 76 | $0 (2024) |
| ABBVIE INC. | $852.45 | 54 | $0 (2024) |
| Novo Nordisk Inc | $666.09 | 43 | $0 (2024) |
| Lilly USA, LLC | $517.06 | 29 | $0 (2024) |
| Amarin Pharma Inc. | $490.89 | 25 | $0 (2022) |
| Allergan, Inc. | $475.21 | 24 | $0 (2021) |
| Esperion Therapeutics, Inc. | $456.97 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $324.68 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $290.15 | 22 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,451 | 81 | AstraZeneca Pharmaceuticals LP ($441.59) |
| 2023 | $1,672 | 97 | AstraZeneca Pharmaceuticals LP ($390.45) |
| 2022 | $1,408 | 83 | AstraZeneca Pharmaceuticals LP ($318.65) |
| 2021 | $1,340 | 86 | Esperion Therapeutics, Inc. ($167.14) |
| 2020 | $1,151 | 69 | Amarin Pharma Inc. ($320.23) |
| 2019 | $715.47 | 41 | Allergan Inc. ($308.16) |
| 2018 | $657.86 | 41 | Amgen Inc. ($201.22) |
| 2017 | $821.44 | 55 | AstraZeneca Pharmaceuticals LP ($195.54) |
All Payment Transactions
553 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.60 | General |
| 09/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes Care | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Philips North America LLC | (CK6) Holter (Device) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: Medical Device | ||||||
| 08/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,271 | 1,848 | $267,532 | $138,747 |
| 2022 | 21 | 1,451 | 2,111 | $295,149 | $156,765 |
| 2021 | 24 | 1,666 | 2,521 | $316,743 | $178,030 |
| 2020 | 25 | 1,770 | 2,606 | $304,143 | $159,591 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 377 | 780 | $142,740 | $62,185 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 331 | 331 | $49,650 | $42,206 | 85.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 354 | 447 | $57,663 | $23,848 | 41.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 48 | 48 | $3,850 | $3,453 | 89.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 20 | $5,300 | $3,219 | 60.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 46 | 46 | $1,840 | $1,387 | 75.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 24 | 50 | $1,750 | $811.00 | 46.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,168 | $525.20 | 45.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 60 | $2,160 | $524.05 | 24.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 19 | 19 | $570.00 | $416.10 | 73.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $756.00 | $118.00 | 15.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 12 | 17 | $85.00 | $54.57 | 64.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 375 | 805 | $147,315 | $66,390 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 307 | 307 | $46,050 | $40,528 | 88.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 348 | 469 | $60,501 | $23,964 | 39.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 24 | 24 | $7,200 | $6,699 | 93.0% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $3,000 | $2,903 | 96.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 17 | $4,505 | $2,877 | 63.9% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 11 | 11 | $3,520 | $2,397 | 68.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 27 | 27 | $2,160 | $1,897 | 87.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 26 | 27 | $3,672 | $1,598 | 43.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 50 | 50 | $2,000 | $1,467 | 73.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $1,500 | $1,371 | 91.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 38 | 38 | $2,774 | $1,183 | 42.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,607 | $836.91 | 32.1% |
About Dr. Thomas Hubbard, MD
Dr. Thomas Hubbard, MD is a Family Medicine healthcare provider based in Ashland, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588633267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Hubbard, MD has received a total of $9,216 in payments from pharmaceutical and medical device companies, with $1,451 received in 2024. These payments were reported across 553 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,948).
As a Medicare-enrolled provider, Hubbard has provided services to 6,158 Medicare beneficiaries, totaling 9,086 services with total Medicare billing of $633,132. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Ashland, VA
- Active Since 03/16/2006
- Last Updated 06/22/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588633267
Products in Payments
- FARXIGA (Drug) $914.63
- UBRELVY (Drug) $529.16
- Vascepa (Drug) $490.89
- NEXLETOL (Drug) $439.27
- BREZTRI (Drug) $364.27
- Otezla (Drug) $276.03
- Repatha (Biological) $272.90
- VRAYLAR (Drug) $259.38
- JARDIANCE (Drug) $252.54
- NATRELLE (Device) $250.00
- AIRSUPRA (Drug) $241.17
- XARELTO (Drug) $226.13
- Ozempic (Drug) $222.94
- TRULICITY (Drug) $221.82
- QULIPTA (Drug) $190.53
- Prolia (Biological) $183.26
- Aimovig (Biological) $181.40
- Rybelsus (Drug) $172.48
- EVENITY (Biological) $167.23
- NURTEC ODT (Drug) $158.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Ashland
Dr. Derek Jones, D.o, D.O
Family Medicine — Payments: $65,426
Jackie Kazee, Md, MD
Family Medicine — Payments: $47,296
Ryan Brang, Md, MD
Family Medicine — Payments: $27,480
Rancie Hannah, Md, MD
Family Medicine — Payments: $16,929
Dr. Abbe Cassity, D.o, D.O
Family Medicine — Payments: $15,073
Larry Fields, Md, MD
Family Medicine — Payments: $13,964